EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A retrospective 10 years‐ experience overview of dye laser treatments for vascular pathologies

Cannarozzo Giovanni, Pennati Beatrice Marina iD, Zingoni Tiziano

Skin Research and Technology · 2023

DOI: 10.1111/srt.13427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Research and Technology, 2023. Verfasst von Cannarozzo Giovanni und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lasers in Dermatology Unit, Università Roma Tor Vergata, Rome, Italy. Hauptthemen laut MEDLINE: Lasers, Dye, Rhinophyma, Hemangioma, Vascular Malformations. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The Flash‐lamp pulsed dye laser (FPDL) is nowadays considered the most precise laser currently on the market for treating superficial vascular lesions. In this study, we gathered data from 10 years of experience regarding dye laser treatment of patients presenting vascular malformations such as telangiectasia, rhinophyma, port‐wine stain, cherry and spider angioma and vascular tumours.

Methods

Subjects were enrolled from 2013 to 2023 based on the vascular anomalies they presented. They underwent different treatment sessions with the FPDL device.

Results

The age‐range distribution by vascular anomaly confirmed that haemangiomas are typical in children while rhinophyma is a condition very common in older adults. A difference in sex distribution showed that pathologies such as telangiectasias typically affect women whereas rhinophyma is more frequent in men. Most of the treatments interested the face area but no permanent side effects were registered.

Conclusions

Our 10 years of experience with FPDL demonstrated good results in a wide range of applications for the treatment of different vascular anomalies. The absence of long‐term side effects and bearable pain during the treatment makes it a valuable solution for the resolution of benign tumours also in very young patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lasers, DyeRhinophymaHemangiomaVascular MalformationsFemaleHumansMaleRetrospective Studies

Stichwörter der Autor:innen

cherry angiomadye laserinfantile haemangiomaport wine stainrhinophymaspider angiomatelangiectasiavascular pathologiesvascular tumours

Autor:innen und Institutionen

  • Lasers in Dermatology Unit, Università Roma Tor Vergata, Rome, Italy.
  • Clinical Research and Practice Department, El.En. Group, Calenzano, Italy.

ORCID-Profile: Pennati Beatrice Marina

Zitieren

APA

Giovanni, C., Marina, P. B., & Tiziano, Z. (2023). A retrospective 10 years‐ experience overview of dye laser treatments for vascular pathologies. Skin Research and Technology. https://doi.org/10.1111/srt.13427

Vancouver

Giovanni C, Marina PB, Tiziano Z. A retrospective 10 years‐ experience overview of dye laser treatments for vascular pathologies. Skin Research and Technology. 2023. doi:10.1111/srt.13427

BibTeX
@article{Giovanni2023,
  author = {Giovanni, Cannarozzo and Marina, Pennati Beatrice and Tiziano, Zingoni},
  title = {A retrospective 10 years‐ experience overview of dye laser treatments for vascular pathologies},
  journal = {Skin Research and Technology},
  year = {2023},
  doi = {10.1111/srt.13427}
}
Kostenlos starten →